Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Search by expertise, name or affiliation
A Phase 3 Randomized, Observer-blind Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Lyophilized Formulation of the Vaccine Candidate BNT162b2 Against COVID-19 in Healthy Adults 18 through 55 years of Age.
Rupp, Richard
(PI)
Pediatrics
Project
:
Research project
Overview
Project Details
Status
Active
Effective start/end date
3/11/21
→
3/10/25
Funding
Pfizer, Inc ( Award # ):
$12,090.00
View all
View less